TickerFactsScreenerDevelopers

HERON THERAPEUTICS, INC. /DE/ (HRTX) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2016: $35.0K2017: $4.59M2018: $27.51M2019: $61.62M2020: $36.19M2021: $46.02M2022: $54.87M2023: $65.11M2024: $38.65M2025: $41.35M$41.35M
2016Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$41.35M+7.0%
2024$38.65M-40.6%
2023$65.11M+18.6%
2022$54.87M+19.2%
2021$46.02M+27.2%
2020$36.19M-41.3%
2019$61.62M+124.0%
2018$27.51M+499.7%
2017$4.59M+13008.6%
2016$35.0K—